+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 3Years - 20Years
All Genders
ID06941389

Studying Long-Term Outcomes of Stem Cell Transplant Versus Non-Transplant Therapies in Children and Teens with Sickle Cell Disease

Led by University of Rochester · Updated on 2026-06-04

480

Participants Needed

37

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing the long-term effects of two treatment options for children with sickle cell disease SCD matched related donor hematopoietic stem cell transplantation MRD HCT and non-transplant disease-modifying therapies NT-DMT. This large observational study focuses on children aged 3 to 20.9 years and aims to evaluate health-related quality of life, cognitive function, risks, benefits, survival rates, chronic complications, and prevention of organ damage associated with these treatments. The study also considers disease severity, treatment history, and social factors that might affect outcomes. The study includes two groups 160 children receiving MRD HCT and 320 children receiving NT-DMT. The MRD HCT group is assessed before transplantation and at several points afterward, while the NT-DMT group is assessed at the start and then annually for three years. Both groups are monitored to understand the treatments effects on disease progression, healthcare use, and overall health. The study uses methods to fairly compare the two groups by accounting for differences in their characteristics. Participants are followed for three years, during which they complete assessments of quality of life and cognitive function at baseline and yearly follow-ups. Researchers collect data on hospital visits, treatment use, and chronic health issues, including graft-versus-host disease for those in the transplant group. The study measures outcomes using standard questionnaires and cognitive tests to provide insights that will help families and healthcare providers make informed treatment decisions for children with SCD.

CONDITIONS

Brief Title

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Research Team

J

John Horan, MD, MPH

S

Savannah Pangrazio, BS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here